Endocarditis physical examination: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
{{SI}}
{{Endocarditis}}


{{CMG}}
{{CMG}}; '''Associate Editors-in-Chief:''' {{CZ}}
 
'''Associate Editors-in-Chief:''' {{CZ}}


{{EJ}}
{{EJ}}
Line 56: Line 54:
{{reflist|2}}
{{reflist|2}}


[[Category:Emergency medicine]]
[[Category:Cardiology]]
[[Category:Cardiology]]
[[Category:Emergency medicine]]
[[Category:Infectious disease]]
[[Category:Infectious disease]]
[[Category:Intensive care medicine]]
[[Category:Intensive care medicine]]
[[Category:Up-To-Date]]


{{WH}}
{{WH}}
{{WS}}
{{WS}}

Revision as of 13:52, 11 September 2011

Endocarditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Infective Endocarditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications & Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

Diagnosis and Follow-up

Medical Therapy

Intervention

Case Studies

Case #1

Endocarditis physical examination On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Endocarditis physical examination

CDC onEndocarditis physical examination

Endocarditis physical examination in the news

Blogs on Endocarditis physical examination

to Hospitals Treating Endocarditis physical examination

Risk calculators and risk factors for Endocarditis physical examination

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-in-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [3] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Vital Signs

  • A fever will likely be present.
  • Rigors may be present.
  • Some patients may have a wide pulse pressure due to aortic insufficiency. If the pulse pressure narrows, this may be a sign of left ventricular failure due to earlier closure of the mitral valve and a more rapid rise in the left ventricular end diastolic pressure which will in turn raise the diastolic pressure.

Skin

  • Petechiae are present in 10% to 40% of patients
  • Splinter hemorrhages are present in 5% to 15% of patients
  • Osler's nodes which are tender subcutaneous nodules in pulp of digits are present in 7% to 10% of patients
  • Janeway lesions which are erythematous, nontender lesions on palm or sole are present in 6% to 10% of patients

Eyes

Roth's spots (white centered hemorrhage)


Ear Nose and Throat

In patients in whom there is new acute onset of aortic regurgitation, bobbing of the uvula may be present.

Heart

Lungs

Abdomen

  • Abdominal pain may be present due to mesenteric embolization or ileus both of which may manifest as reduced bowel sounds
  • Splenomegaly may be present in 15% to 30% patients.
  • Left upper quadrant (LUQ) pain may be present as a result of a splenic infarct from embolization.
  • Flank pain may be present as a result of an embolus to the kidney

Extremities

Osler's nodes


Neurologic

References


Template:WH Template:WS